Get the Stockscreener App
1.76
11.11%
-0.22
Pre-market:
1.73
-0.03
-1.70%
Aptevo Therapeutics Inc stock is traded at $1.76, with a volume of 6.21M.
It is down -11.11% in the last 24 hours and down -11.56% over the past month.
Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.
See More
Previous Close:
$1.98
Open:
$1.89
24h Volume:
6.21M
Relative Volume:
1.08
Market Cap:
$5.79M
Revenue:
$12.99M
Net Income/Loss:
$-23.72M
P/E Ratio:
-0.0181
EPS:
-97.2514
Net Cash Flow:
$-23.28M
1W Performance:
+19.73%
1M Performance:
-11.56%
6M Performance:
-96.65%
1Y Performance:
-98.65%
1-Day Range:
$1.75
$1.99
1-Week Range:
$1.32
$2.71
52-Week Range:
$1.32
$381.10
Aptevo Therapeutics Inc Stock (APVO) Company Profile
Name
Aptevo Therapeutics Inc
Sector
Industry
Phone
206-838-0500
Address
2401 4TH AVE., SEATTLE, WA
Compare APVO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
APVO
Aptevo Therapeutics Inc
|
1.76 | 6.51M | 12.99M | -23.72M | -23.28M | -97.25 |
|
VRTX
Vertex Pharmaceuticals Inc
|
383.12 | 99.25B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
591.99 | 63.46B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.56 | 59.27B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
736.76 | 44.78B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
334.40 | 37.75B | 3.81B | -644.79M | -669.77M | -6.24 |
Aptevo Therapeutics Inc Stock (APVO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-05-18 | Initiated | Ladenburg Thalmann | Buy |
| Oct-05-17 | Resumed | Piper Jaffray | Overweight |
Aptevo Therapeutics Inc Stock (APVO) Latest News
Earnings Report: What drives Aptevo Therapeutics Incs stock priceJuly 2025 Intraday Action & Weekly Sector Rotation Insights - خودرو بانک
Price Action: What is Aptevo Therapeutics Incs 5 year growth outlookWeekly Trading Summary & Growth Focused Entry Reports - khodrobank.com
Entry Recap: Is NWPX trading at a discountSwing Trade & Technical Entry and Exit Alerts - khodrobank.com
Foremost Clean Energy and Aptevo Therapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Corpus Christi Caller-Times
Insider Sell: Is Aptevo Therapeutics Inc. stock trending bullishTrade Ideas & High Accuracy Trade Signal Alerts - خودرو بانک
Dividend Watch: Is Aptevo Therapeutics Inc a defensive stockTrade Risk Summary & Weekly High Momentum Picks - خودرو بانک
Profit Recap: Is Aptevo Therapeutics Inc impacted by rising ratesTrade Exit Report & Fast Moving Stock Watchlists - خودرو بانک
Aptevo Therapeutics Stock Plummets to New 52-Week Low of $1.32 - Markets Mojo
Block Trades: What is Aptevo Therapeutics Inc. s 5 year growth outlook2025 Buyback Activity & Precise Trade Entry Recommendations - khodrobank.com
Options Flow: Does Aptevo Therapeutics Inc. offer margin of safety2025 Market Trends & Weekly Chart Analysis and Guides - خودرو بانک
Bull Bear: Can Aptevo Therapeutics Inc navigate macro headwinds2025 Trade Ideas & Fast Exit/Entry Strategy Plans - خودرو بانک
Aptevo Therapeutics Inc. (APVO) Stock Price | Live Quotes & Charts | NSC - StocksToTrade
FOMO Trade: How liquid is Aptevo Therapeutics Inc stockQuarterly Market Summary & AI Enhanced Trading Alerts - خودرو بانک
Why Is Aptevo Therapeutics Stock (APVO) Up 85% Today? - TipRanks
Aptevo Therapeutics: Surprising Results in AML Trial! - StocksToTrade
Nasdaq Surges 100 Points; US Initial Jobless Claims Fall - Benzinga
Morning Market Movers: ETNB, APVO, PBM, BEEM See Big Swings - RTTNews
Intel, Nike, Aptevo - TradingView
Aptevo soars after billionaire investor discloses stake - TradingView
Why Bullish Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket - Benzinga
Aptevo Therapeutics Surges Over 46% After Hours On Breakthrough AML Treatment Results - Benzinga
Biotech Stocks To Add to Your WatchlistSeptember 16th - MarketBeat
Tech Rally: Does RANG outperform in volatile marketsM&A Rumor & Long-Term Safe Investment Plans - خودرو بانک
Aug Closing: How do insiders feel about Bleichroeder Acquisition Corp. IWeekly Profit Recap & Low Drawdown Trading Strategies - خودرو بانک
Aptevo says mipletamig deliver 100% remission rate in RAINIER cohort 3 - TipRanks
Aptevo Announces 100% Remission in AML Trial - TipRanks
Insider Trends: Whats next for Aptevo Therapeutics Inc stockWeekly Stock Recap & Community Supported Trade Ideas - خودرو بانک
APVO Stock Surge: A Time to Consider? - timothysykes.com
Why Is Aptevo Therapeutics Stock (APVO) Up 50% Today? - TipRanks
Aptevo Therapeutics Stock Rallies On 100% Remission Rate In Acute Myeloid Leukemia Trial Cohort - Stocktwits
Sentiment Recap: Is Aptevo Therapeutics Inc stock a value trap2025 Volatility Report & Fast Moving Stock Watchlists - خودرو بانک
APVO Stock Jumps over 4%: Why Aptevo (APVO) Stock Is Trading Higher Today? - Markets.com
Aug Closing: Is Rithm Property Trust Inc. forming a breakout pattern2025 Institutional Moves & Expert Curated Trade Setup Alerts - خودرو بانک
Ark, Atom file to go public in Hong Kong; Aptevo’s stock rallies on AML data - Endpoints News
Aptevo Therapeutics Shares Soar Following 100% Remission Rate in AML Trial - MSN
Aptevo jumps after blood cancer therapy shows 100% remission in trial - TradingView
Aptevo Therapeutics Hits New 52-Week Low at $1.41 - Markets Mojo
Aptevo Therapeutics stock soars after 100% remission rate in AML trial - Investing.com UK
Aptevo Therapeutics stock soars after 100% remission rate in AML trial By Investing.com - Investing.com Canada
Market movers: Webtoon Entertainment, Hershey, Rocket Lab, Aptevo Therapeutics… - Proactive financial news
Aptevo Therapeutics Surge: New Molecules Boost Stock - StocksToTrade
100% Remission Rate: Aptevo's Novel AML Drug Shows Perfect Response in Latest Trial Cohort, Zero Toxicity - Stock Titan
Aptevo Therapeutics shares spike on promising trial results for leukemia therapy - Proactive financial news
Aug Highlights: What is Aptevo Therapeutics Incs valuation compared to sectorJuly 2025 Market Mood & Daily Profit Maximizing Trade Tips - خودرو بانک
How high can Aptevo Therapeutics Inc. stock goTrade Exit Summary & AI Powered Buy/Sell Recommendations - newser.com
Developing predictive dashboards with Aptevo Therapeutics Inc. dataMarket Trend Report & Real-Time Price Movement Reports - newser.com
Targets Report: Is Aptevo Therapeutics Inc stock trending bullishTrade Signal Summary & Verified Swing Trading Watchlist - خودرو بانک
Can a trend reversal in Aptevo Therapeutics Inc. lead to recoveryMarket Activity Recap & Real-Time Market Trend Scan - newser.com
Aug Update: What drives Aptevo Therapeutics Incs stock priceTrade Entry Report & Weekly Market Pulse Updates - خودرو بانک
Pharma News: What is Aptevo Therapeutics Incs valuation compared to sectorJuly 2025 Institutional & Fast Moving Stock Trade Plans - خودرو بانک
Risk Analysis: Is Aptevo Therapeutics Inc. stock forming a triangle patternJuly 2025 Short Interest & Stepwise Trade Execution Plans - خودرو بانک
Aptevo Therapeutics Inc Stock (APVO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.43%
0.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):